Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 4
2005 3
2007 5
2008 4
2009 2
2010 5
2011 3
2012 3
2013 2
2014 4
2015 3
2016 7
2017 6
2018 3
2019 3
2020 8
2021 9
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
Lasarte-Monterrubio C, Fraile-Ribot PA, Vázquez-Ucha JC, Cabot G, Guijarro-Sánchez P, Alonso-García I, Rumbo-Feal S, Galán-Sánchez F, Beceiro A, Arca-Suárez J, Oliver A, Bou G. Lasarte-Monterrubio C, et al. Among authors: beceiro a. J Antimicrob Chemother. 2022 Sep 30;77(10):2809-2815. doi: 10.1093/jac/dkac241. J Antimicrob Chemother. 2022. PMID: 35904000
Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing Enterobacterales.
Vázquez-Ucha JC, Lasarte-Monterrubio C, Guijarro-Sánchez P, Oviaño M, Álvarez-Fraga L, Alonso-García I, Arca-Suárez J, Bou G, Beceiro A; GEMARA-SEIMC/REIPI Enterobacterales Study Group. Vázquez-Ucha JC, et al. Among authors: beceiro a. Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0167621. doi: 10.1128/AAC.01676-21. Epub 2021 Nov 22. Antimicrob Agents Chemother. 2022. PMID: 34807754 Free PMC article.
New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams.
Vázquez-Ucha JC, Arca-Suárez J, Bou G, Beceiro A. Vázquez-Ucha JC, et al. Among authors: beceiro a. Int J Mol Sci. 2020 Dec 6;21(23):9308. doi: 10.3390/ijms21239308. Int J Mol Sci. 2020. PMID: 33291334 Free PMC article. Review.
Direct Detection of Carbapenemase-Producing Klebsiella pneumoniae by MALDI-TOF Analysis of Full Spectra Applying Machine Learning.
Gato E, Arroyo MJ, Méndez G, Candela A, Rodiño-Janeiro BK, Fernández J, Rodríguez-Sánchez B, Mancera L, Arca-Suárez J, Beceiro A, Bou G, Oviaño M. Gato E, et al. Among authors: beceiro a. J Clin Microbiol. 2023 Jun 20;61(6):e0175122. doi: 10.1128/jcm.01751-22. Epub 2023 May 18. J Clin Microbiol. 2023. PMID: 37199638 Free PMC article.
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain.
Vázquez-Ucha JC, Alonso-Garcia I, Guijarro-Sánchez P, Lasarte-Monterrubio C, Álvarez-Fraga L, Cendón-Esteve A, Outeda M, Maceiras R, Peña-Escolano A, Martínez-Guitián M, Arca-Suárez J, Bou G, Beceiro A; GEMARA-SEIMC/REIPI Enterobacterales Study Group. Vázquez-Ucha JC, et al. Among authors: beceiro a. Int J Antimicrob Agents. 2023 Apr;61(4):106738. doi: 10.1016/j.ijantimicag.2023.106738. Epub 2023 Feb 3. Int J Antimicrob Agents. 2023. PMID: 36736925
Involvement of HisF in the Persistence of Acinetobacter baumannii During a Pneumonia Infection.
Martínez-Guitián M, Vázquez-Ucha JC, Álvarez-Fraga L, Conde-Pérez K, Lasarte-Monterrubio C, Vallejo JA, Bou G, Poza M, Beceiro A. Martínez-Guitián M, et al. Among authors: beceiro a. Front Cell Infect Microbiol. 2019 Aug 29;9:310. doi: 10.3389/fcimb.2019.00310. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31555607 Free PMC article.
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
Alonso-García I, Vázquez-Ucha JC, Lasarte-Monterrubio C, González-Mayo E, Lada-Salvador P, Vela-Fernández R, Aja-Macaya P, Guijarro-Sánchez P, Rumbo-Feal S, Muíño-Andrade M, Fernández-González A, Martínez-Guitián M, Beceiro A, Rodríguez-Iglesias M, Oliver A, Arca-Suárez J, Galán-Sánchez F, Bou G. Alonso-García I, et al. Among authors: beceiro a. J Antimicrob Chemother. 2023 May 3;78(5):1195-1200. doi: 10.1093/jac/dkad062. J Antimicrob Chemother. 2023. PMID: 36918743
83 results